Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia
|2||Not yet recruiting||
Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice
|3||Active, not recruiting||
Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS
A Pilot Study of ODSH in Acute Myeloid Leukemia
† Study has passed its completion date and status has not been verified in more than two years.